NorthWest Biotherapeutics Inc (NWBO): Manibiotec, yes I agree, l looked at 1 M... (2024)

Public Reply Private Reply New Post

Replies (2) Keep Next 10 Report Keyboard Shortcuts

Manibiotec, yes I agree, l looked at 1 Mont, 3 month, ytd, 6 month, one year, and 3 year chart and yesterday posted that all are down. The 4 and 5 year charts show gains but in this stock I go back to 2015 and is not a nice chart. It was my decision but many years back I sold another stock to purchase more nwbo and that other stock went well over $100 a share and nwbo (at least to now) is a very far cry from 100+ a share. I have talked utmost respect for the researchers but took me a long time to take what I hear from nwbo with a grain of salt. I used to speak with Les Goldman at least every month and I do like the guy but imo they lack the experience to move forward in a timely manner. I have often thought they should add a person with such experience to the management team. They have a good product (imo) but certainly has been a struggle to get it to market. Dilution in such companies is expected but when I started the outstanding shares were less than 100 million and now a bit higher than that - like 10 to 15 times. Imo the statement from LP that all big pjarma brings is a checkbook, well they needed that checkbook. I still think they should get approval in UK but the real potential revenue comes with fda approval and as the vaccine is at least as good as temozolomide (part of soc) imo should also be able to get US approval. Both temozolomide and dcvax add at median about 3 months to os and dcvax has the long tail survivors. Partner up and get this thing out there

Replies (2) Next 10 Prev Next

• Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
• Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
• Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
• Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
• Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
• Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
• Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
• Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
• Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
• Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM

More NWBO News

InvestorsHub NewsWire

Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM

Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM

"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM

North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM

Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM

Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM

Start posting your company's news

Only $200 per official company press release!